Navigation Links
Major Physician Group Issues Statement in Support of Physician/Industry Relationships
Date:5/15/2009

HOUSTON, May 15 /PRNewswire-USNewswire/ -- The American Association of Clinical Endocrinologists and the American College of Endocrinology (AACE and ACE) today released a Position Statement on Physician/Industry Relationships. The position is a strong statement in support of continuing the beneficial and ethical collaboration between physicians and industry.

(Logo: http://www.newscom.com/cgi-bin/prnh/20090324/DC88061LOGO-b)

The statement, shown below in its entirety, was released at the AACE 18th Annual Meeting and Clinical Congress in Houston.

"The American Association of Clinical Endocrinologists and The American College of Endocrinology (AACE and ACE) believe that interaction between physicians and industry has contributed to safe, effective, and value- oriented health care. AACE and ACE affirm that relationships between physicians and industry have been overwhelmingly consistent with ethical standards and responsive to the needs of patients.

There is no inherent conflict of interest in the working relationship of physicians with industry and government. Rather, there is a commonality of interest that is healthy, desirable, and beneficial. The collaborative and constructive relationship among physicians, government, and industry has resulted in many medical advancements and improved health outcomes.

Since their inception, AACE and ACE have formulated policies and procedures to guide the conduct of the organizations and their members in cooperative interactions with industry and with government. These policies are continually being updated to reflect the changing practice and health care environment. AACE and ACE are committed to preserving relationships, including those with industry and with government, that contribute to the fulfillment of their basic mission: to enhance physicians' ability to provide the highest quality of medical care for patients with endocrine disorders."

-AACE and ACE Position Statement on Physician/Industry Relationships

May 15, 2009

"Physician and industry collaboration has advanced the treatment of major illnesses such as diabetes, heart disease, osteoporosis, high cholesterol and hypertension," said Daniel Duick, MD, FACP FACE, and President of the AACE. "The overwhelming majority of physicians, in all fields of healthcare, evaluate and apply advances that are deemed effective, safe and result in best clinical practice outcomes; and, they do so with their patients in mind, and not for pharmaceutical perks."

The Position Statement will be published in the May/June issue of Endocrine Practice, the Journal of the American Association of Clinical Endocrinologists.

To view a copy of the AACE and ACE policies and procedures regarding the disclosure of conflicts of interest, please click here.

For more information on the AACE 18th Annual Meeting and Clinical Congress, click here.

A short, one page bio and high resolution photo of AACE President Daniel Duick, MD, FACP, FACE, are available here.

About AACE

AACE is a professional medical organization with more than 6,200 members in the United States and 92 other countries. Founded in 1991, AACE is dedicated to the optimal care of patients with endocrine problems. AACE initiatives inform the public about endocrine disorders. AACE also conducts continuing education programs for clinical endocrinologists, physicians whose advanced, specialized training enables them to be experts in the care of endocrine diseases, such as diabetes, thyroid disorders, growth hormone deficiency, osteoporosis, cholesterol disorders, hypertension and obesity.


'/>"/>
SOURCE American Association of Clinical Endocrinologists
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Majority of 2.4 Million U.S. Children With ADHD Not Diagnosed or Consistently Treated, According to New Gold Standard Study by Cincinnati Childrens Researchers
2. Laboratory at UI plays major role in diagnosing cancer
3. Draxis Health selected by Johnson and Johnson Consumer Companies, Inc. for major contract manufacturing relationship
4. DaVita Acquires Majority Stake in HomeChoice Partners, Inc.
5. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
6. Major grant advances UWs clinical and translational research enterprise
7. Major differences revealed in how local authorities in the UK support disabled people
8. Watson Wyatt Identifies Major Benefit Trends During Open Enrollment Season
9. Worldwide Probiotic Drink, Yakult(R), Launches in Its First Major U.S. Market
10. Ericom Provides Significant Cost-Savings for Major New York City Healthcare Organization
11. Eckert Seamans Announces Major Expansion in Philadelphia, West Chester and Harrisburg
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... ... , ... The International Association of Eating Disorders Professionals (iaedp) announces the 2017 ... image mannequin art competition. Selected from 15 submissions from around the nation, the top ... 31st annual iaedp Symposium, March 22 – 26 in Las Vegas. , This year, ...
(Date:2/24/2017)... ... 24, 2017 , ... Castle Farms, the celebrated Northern ... with the winning couple announced on Feb. 14, 2017, on Facebook. The free ... vendors: A Matter of Taste, Ryan Rousseau Enterprises, A Touch of Spring and ...
(Date:2/23/2017)... ... February 23, 2017 , ... Rare Disease Report®, which is ... in Rare Disease Day events, hosted by the Rare Disease Legislative Advocates (RDLA) ... website, weekly e-newsletter and quarterly publication, will be conducting interviews with patients and ...
(Date:2/23/2017)... ... February 23, 2017 , ... EBSCO Information ... National Institute for Health and Care Excellence (NICE) framework. The agreement ... Health Service (NHS) to search, order and purchase medical and healthcare-related content through ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... today that it will soon begin franchising throughout the U.S. starting this spring. ... help bring the practice of meditation mainstream. Current Meditation will be the first ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... NEW YORK , Feb. 23, 2017 /PRNewswire/ ... USD 330.6 million by 2021 from USD 275.9 ... Read the full report: http://www.reportlinker.com/p04718602-summary/view-report.html ... industries, increasing spending on pharmaceutical R&D, and growth ... factors driving the market growth for particle counters. ...
(Date:2/23/2017)... Research and Markets has announced the addition of the ... report to their offering. ... The latest research Autism Spectrum Disorder Drugs Price Analysis ... the global Autism Spectrum Disorder market. The research answers the ... drugs marketed for Autism Spectrum Disorder and their clinical attributes? How ...
(Date:2/23/2017)... Calif., Feb. 23, 2017 Nevro Corp. (NYSE: NVRO), ... solutions for the treatment of chronic pain, today reported financial ... 31, 2016. 2016 Accomplishment & Highlights: ... year 2016, an increase of 228% as reported, over the ... 2016, an increase of 612% over the prior year ...
Breaking Medicine Technology: